Advertisement

International Journal of Clinical Pharmacy

, Volume 38, Issue 2, pp 454–461 | Cite as

Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy

  • Alessandro Galazzi
  • Maura Lusignani
  • Maria Teresa Chiarelli
  • Pier Mannuccio Mannucci
  • Carlotta Franchi
  • Mauro Tettamanti
  • Emily Reeve
  • Alessandro Nobili
Research Article

Abstract

Background From 20 to 65 % of older adults receiving polypharmacy take at least one potentially inappropriate medication (PIM), leading to a high risk of adverse drug reactions. The term deprescribing was coined to describe a process of optimization of drug regimens through the withdrawal of PIMs. There is a paucity of evidence on the attitudes, beliefs and willingness of hospitalized patients towards deprescribing. Objective To measure at hospital discharge inpatients’ attitudes and beliefs towards polypharmacy and the potential withdrawal of one or more of their medications using the PATD (Patients’ Attitudes Towards Deprescribing) questionnaire and determine if they are associated with participant characteristics. Setting Geriatric and internal medicine wards in an Italian teaching hospital. Method Administration of the PATD questionnaire (developed and validated in an Australian outpatient setting, translated and adapted to the Italian setting for this study) to a consecutive sample of 100 older (aged ≥65 years) inpatients with polypharmacy who were interviewed by a nurse or pharmacist at the time of hospital discharge. Main outcome measure Older patients’ attitudes and beliefs towards reducing medications and participant characteristics. Results Eighty-nine percent of patients surveyed would like to reduce the number of daily medications. The desire for deprescribing was not associated with age, sex or number of medications or medical conditions; older patients were less aware of the reasons for taking medications. Conclusion The majority of hospitalized older adults with polypharmacy think they are taking a lot of drugs and would like to reduce this number. Older adults should not be considered a major limitation on deprescribing interventions. Future research should examine this issue with qualitative studies in order to gain a more in-depth understanding and explore how these findings can be translated into a multidisciplinary deprescribing process.

Keywords

Deprescribing Italy Older adults Patient attitudes Polypharmacy Potentially inappropriate medications (PIMs) Withdrawal 

Notes

Acknowledgments

The authors would like to acknowledge Vito Ladisa, Luca Pasina, Ilaria Speranza and Djignefa Djade Codjo for their contribution to the study development and data analysis.

Funding

None.

Conflicts of interest

The authors have no conflicts of interest to declare.

References

  1. 1.
    World Health Organization. Adherence to long-term therapies: evidence for action [online] (2013) [cited 2013 on Sept 7]. http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html.
  2. 2.
    Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345–51.CrossRefPubMedGoogle Scholar
  3. 3.
    Banning M. Medication management: older people and nursing. Nurs Older People. 2005;17(7):20–3.PubMedGoogle Scholar
  4. 4.
    Frazier SC. Health outcomes and polypharmacy in elderly individuals. J Gerontol Nurs. 2005;31(9):4–11.CrossRefPubMedGoogle Scholar
  5. 5.
    Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ. 2011;21(342):d3514.CrossRefGoogle Scholar
  6. 6.
    Giustini S, Thiry S. Medicina generale, multi morbilità e politerapia nei pazienti anziani. Riv Soc Italiana di Med Gen. 2012;6:11–4.Google Scholar
  7. 7.
    George J, Elliott RA, Stewart DC. A systematic review of interventions to improve medication taking in elderly patient prescribed multiple medications. Drugs Aging. 2008;25(4):307–24.CrossRefPubMedGoogle Scholar
  8. 8.
    Elmo A, Ruggiero C, Dell’aquila G, Gasperini B, Cherubini A. Inappropriate drug prescription in elderly nursing home residence. G Gerontol. 2010;58:151–61.Google Scholar
  9. 9.
    Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84 Review.CrossRefPubMedGoogle Scholar
  10. 10.
    Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61(9):1508–14 Epub 2013 Aug 26.CrossRefPubMedGoogle Scholar
  11. 11.
    Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy. Arch Intern Med. 2010;170:1648–54.CrossRefPubMedGoogle Scholar
  12. 12.
    Onder G, Bonassi S, Abbatecola AM, Folino-Gallo P, Lapi F, Marchionni N, et al. High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA). J Gerontol A Biol Sci Med Sci. 2014;69(4):430–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Best Practice Journal. A practical guide to stopping medicines in older people [online] (2013) [cited 2013 on Sept 29]. http://www.bpac.org.nz/BPJ/2010/April/docs/bpj_27_stop_guide_pages_10-23.pdf.
  14. 14.
    Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–68.CrossRefPubMedGoogle Scholar
  15. 15.
    Gnjidic D, Le Couteur DG, Pearson SA, McLachlan AJ, Viney R, Hilmer SN, et al. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health. 2013;7(13):115.CrossRefGoogle Scholar
  16. 16.
    Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medication. J Pharm Pract Res. 2003;33:323–8.CrossRefGoogle Scholar
  17. 17.
    O’Connor M, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437.CrossRefPubMedGoogle Scholar
  18. 18.
    Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. Stopp (screening tool of older person’s prescriptions) and start (screening tool to alert doctors to right treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.CrossRefPubMedGoogle Scholar
  19. 19.
    Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRefPubMedGoogle Scholar
  20. 20.
    Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738–47.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Scott IA, Hilmer SN, Reeve E, Potter K, Couteur DL, Rigby D, et al. Reducing inappropriate polypharmacy: The process of deprescribing. JAMA Intern Med. 2015;Published online March 23.Google Scholar
  22. 22.
    Murray E, Pollack L, White M, Lo B. Clinical decision-making: patients’ preferences and experiences. Patient Educ Couns. 2006;65:189–96.CrossRefPubMedGoogle Scholar
  23. 23.
    Williams ME, Pulliam CC, Hunter R, et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc. 2004;52:93–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.CrossRefPubMedGoogle Scholar
  25. 25.
    Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm. 2013;35(1):51–6 Epub 2012 Oct 9.CrossRefPubMedGoogle Scholar
  26. 26.
    Qi K, Reeve E, Hilmer S, Pearson S-A, Matthews S, Gnjidic D. Older peoples’ attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Int J Clin Pharm. 2015;37(5):949–57.Google Scholar
  27. 27.
    Mannucci PM, Nobili A. REPOSI investigators. Multimorbidity and polypharmacy in the elderly: lessons from REPOSI. Intern Emerg Med. 2014;9(7):723–34.CrossRefPubMedGoogle Scholar
  28. 28.
    Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012;5: Art. No.: CD008165.Google Scholar
  29. 29.
    Anderson K, Freeman C, Stowasser D, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4:e006544.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Scott IA, Le Couteur DG. Physicians need to take the lead in deprescribing. Intern Med J. 2015;45:352–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Cullinan S, Fleming A, O’Mahony D, Ryan C, O’Sullivan D, Gallagher P, et al. Doctors’ perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study. Br J Clin Pharmacol. 2015;79(5):860–9.Google Scholar

Copyright information

© Springer International Publishing 2016

Authors and Affiliations

  • Alessandro Galazzi
    • 1
  • Maura Lusignani
    • 2
    • 3
  • Maria Teresa Chiarelli
    • 4
  • Pier Mannuccio Mannucci
    • 5
    • 8
  • Carlotta Franchi
    • 6
  • Mauro Tettamanti
    • 6
  • Emily Reeve
    • 7
    • 9
  • Alessandro Nobili
    • 6
  1. 1.Area Terapie Intensive - SITRAIRCCS Fondazione Ca’ Granda Ospedale Maggiore PoliclinicoMilanItaly
  2. 2.Department of Biomedical Sciences for HealthUniversity of MilanMilanItaly
  3. 3.IRCCS Fondazione Ca’ Granda Ospedale Maggiore PoliclinicoMilanItaly
  4. 4.Clinical PharmacologyIRCCS Fondazione Ca’ Granda Ospedale Maggiore PoliclinicoMilanItaly
  5. 5.A. Bianchi Bonomi Hemophilia and Thrombosis CenterMilanItaly
  6. 6.Department of NeuroscienceIRCCS Istituto di Ricerche Farmacologiche Mario NegriMilanItaly
  7. 7.Cognitive Decline Partnership Centre, Kolling Institute of Medical ResearchRoyal North Shore HospitalSt LeonardsAustralia
  8. 8.IRCCS Fondazione Ca’ Granda Ospedale Maggiore PoliclinicoMilanItaly
  9. 9.University of SydneySydneyAustralia

Personalised recommendations